The 2007 WHO Classification of Tumors of the Nervous System: Controversies in Surgical Neuropathology

od Scheithauer, Bernd W., Fuller, Greg N., VandenBerg, Scott R.
Izdano u Brain Pathol (2008)

In Situ Visualization of Intratumor Growth Factor Signaling : Immunohistochemical Localization of Activated ERK/MAP Kinase in Glial Neoplasms

od Mandell, James W., Hussaini, Isa M., Zecevic, Maja, Weber, Michael J., VandenBerg, Scott R.
Izdano 1998

Crosstalk between the urokinase-type plasminogen activator receptor and EGF receptor variant III supports survival and growth of glioblastoma cells

od Hu, Jingjing, Jo, Minji, Cavenee, Webster K., Furnari, Frank, VandenBerg, Scott R., Gonias, Steven L.
Izdano 2011

The Neurofibromatosis 2 Tumor Suppressor Gene Product, Merlin, Regulates Human Meningioma Cell Growth by Signaling through YAP

od Striedinger, Katherine, VandenBerg, Scott R, Baia, Gilson S, McDermott, Michael W, Gutmann, David H, Lal, Anita
Izdano 2008

Neutralizing the EGF receptor in glioblastoma cells stimulates cell migration by activating uPAR-initiated cell-signaling

od Hu, Jingjing, Muller, Karra A., Furnari, Frank B., Cavenee, Webster K., VandenBerg, Scott R., Gonias, Steven L.
Izdano u Oncogene (2014)

Gene expression profiles help identify the Tissue of Origin for metastatic brain cancers

od Wu, Alan HB, Drees, Julia C, Wang, Hangpin, VandenBerg, Scott R, Lal, Anita, Henner, William D, Pillai, Raji
Izdano 2010

In vivo efficacy of a novel histone deacetylase inhibitor in combination with radiation for the treatment of gliomas

od Entin-Meer, Michal, Yang, Xiaodong, VandenBerg, Scott R., Lamborn, Kathleen R., Nudelman, Abraham, Rephaeli, Ada, Haas-Kogan, Daphne Adele
Izdano 2007

Morphologic and molecular characterization of ATRT xenografts adapted for orthotopic therapeutic testing

od Hashizume, Rintaro, Gupta, Nalin, Berger, Mitchel S., Banerjee, Anu, Prados, Michael D., Ayers-Ringler, Jennifer, James, C. David, VandenBerg, Scott R.
Izdano 2010

Myeloid Cell Receptor LRP1/CD91 Regulates Monocyte Recruitment and Angiogenesis in Tumors

od Staudt, Nicole D., Jo, Minji, Hu, Jingjing, Bristow, Jeanne M., Pizzo, Donald P., Gaultier, Alban, VandenBerg, Scott R., Gonias, Steven L.
Izdano 2013

RESEARCH ARTICLE: An Orthotopic Skull Base Model of Malignant Meningioma

od Baia, Gilson S., Dinca, Eduard B., Ozawa, Tomoko, Kimura, Edna T., McDermott, Michael W., James, C. David, VandenBerg, Scott R., Lal, Anita
Izdano u Brain Pathol (2007)

MRI apparent diffusion coefficient reflects histopathologic subtype, axonal disruption, and tumor fraction in diffuse-type grade II gliomas

od Khayal, Inas S., VandenBerg, Scott R., Smith, Kenneth J., Cloyd, Colleen P., Chang, Susan M., Cha, Soonmee, Nelson, Sarah J., McKnight, Tracy R.
Izdano 2011

Restriction-Spectrum Imaging of Bevacizumab-Related Necrosis in a Patient with GBM

od Farid, Nikdokht, Almeida-Freitas, Daniela B., White, Nathan S., McDonald, Carrie R., Muller, Karra A., VandenBerg, Scott R., Kesari, Santosh, Dale, Anders M.
Izdano 2013

Selective coexpression of VEGF receptor 2 in EGFRvIII-positive glioblastoma cells prevents cellular senescence and contributes to their aggressive nature

od Jones, Karra A., Gilder, Andrew S., Lam, Michael S., Du, Na, Banki, Michael A., Merati, Aran, Pizzo, Donald P., VandenBerg, Scott R., Gonias, Steven L.
Izdano u Neuro Oncol (2016)

Molecular signatures define two main classes of meningiomas

od Carvalho, Lucia Helena, Smirnov, Ivan, Baia, Gilson S, Modrusan, Zora, Smith, Justin S, Jun, Peter, Costello, Joseph F, McDermott, Michael W, VandenBerg, Scott R, Lal, Anita
Izdano 2007

Expression of miR-124 inhibits growth of medulloblastoma cells

od Silber, Joachim, Hashizume, Rintaro, Felix, Tristan, Hariono, Sujatmi, Yu, Mamie, Berger, Mitchel S., Huse, Jason T., VandenBerg, Scott R., James, C. David, Hodgson, J. Graeme, Gupta, Nalin
Izdano 2013

Role of connexins in metastatic breast cancer and melanoma brain colonization

od Stoletov, Konstantin, Strnadel, Jan, Zardouzian, Erin, Momiyama, Masashi, Park, Frederick D., Kelber, Jonathan A., Pizzo, Donald P., Hoffman, Robert, VandenBerg, Scott R., Klemke, Richard L.
Izdano 2013

Ex vivo MR spectroscopic measure differentiates tumor from treatment effects in GBM

od Srinivasan, Radhika, Phillips, Joanna J., VandenBerg, Scott R., Polley, Mei-Yin C., Bourne, Gabriela, Au, Alvin, Pirzkall, Andrea, Cha, Soonmee, Chang, Susan M., Nelson, Sarah J.
Izdano 2010

p53 Small Molecule Inhibitor Enhances Temozolomide Cytotoxic Activity against Intracranial Glioblastoma Xenografts

od Dinca, Eduard B., Lu, Kan V., Sarkaria, Jann N., Pieper, Russell O., Prados, Michael D., Haas-Kogan, Daphne A., VandenBerg, Scott R., Berger, Mitchel S., James, C. David
Izdano 2008

Pediatric Phase II Trials of Poly-ICLC in the Management of Newly Diagnosed and Recurrent Brain Tumors

od Hartman, Lisa L.R., Crawford, John R., Makale, Milan T., Milburn, Mehrzad, Joshi, Shweta, Salazar, Andres M., Hasenauer, Beth, VandenBerg, Scott R., MacDonald, Tobey J., Durden, Donald L.
Izdano u J Pediatr Hematol Oncol (2014)

Hyperpolarized (13)C magnetic resonance metabolic imaging: application to brain tumors

od Park, Ilwoo, Larson, Peder E. Z., Zierhut, Matthew L., Hu, Simon, Bok, Robert, Ozawa, Tomoko, Kurhanewicz, John, Vigneron, Daniel B., VandenBerg, Scott R., James, C. David, Nelson, Sarah J.
Izdano 2010